Chesley Taft & Associates LLC Danaher Corp Transaction History

Chesley Taft & Associates LLC

  • $1.98 Billion
  • Q2 2024

A detailed history of Chesley Taft & Associates LLC transactions in Danaher Corp stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 77,531 shares of DHR stock, worth $21.4 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
77,531
Previous 77,071 0.6%
Holding current value
$21.4 Million
Previous $19.2 Million 0.65%
% of portfolio
0.98%
Previous 0.99%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$235.51 - $267.98 $108,334 - $123,270
460 Added 0.6%
77,531 $19.4 Million
Q1 2024

Apr 15, 2024
BUY
$224.58 - $256.19 $206,164 - $235,182
918 Added 1.21%
77,071 $19.2 Million
Q4 2023

Jan 11, 2024
BUY
$185.1 - $233.13 $119,389 - $150,368
645 Added 0.85%
76,153 $17.6 Million
Q3 2023

Oct 10, 2023
BUY
$233.08 - $265.59 $71,322 - $81,270
306 Added 0.41%
75,508 $18.7 Million
Q2 2023

Jul 17, 2023
SELL
$224.99 - $256.14 $257,613 - $293,280
-1,145 Reduced 1.5%
75,202 $18 Million
Q1 2023

Apr 11, 2023
SELL
$239.75 - $277.0 $4.17 Million - $4.82 Million
-17,409 Reduced 18.57%
76,347 $19.2 Million
Q4 2022

Jan 19, 2023
SELL
$241.42 - $282.29 $214,863 - $251,238
-890 Reduced 0.94%
93,756 $0
Q3 2022

Oct 13, 2022
SELL
$247.06 - $1507.4 $160,836 - $981,317
-651 Reduced 0.68%
94,646 $24.4 Million
Q2 2022

Jul 07, 2022
SELL
$237.11 - $299.66 $208,656 - $263,700
-880 Reduced 0.91%
95,297 $24.2 Million
Q1 2022

Apr 14, 2022
SELL
$257.27 - $315.76 $1.36 Million - $1.67 Million
-5,300 Reduced 5.22%
96,177 $27 Million
Q4 2021

Jan 05, 2022
BUY
$292.08 - $329.01 $186,054 - $209,579
637 Added 0.63%
101,477 $33.4 Million
Q3 2021

Oct 05, 2021
SELL
$272.21 - $332.43 $310,591 - $379,302
-1,141 Reduced 1.12%
100,840 $30.7 Million
Q2 2021

Jul 07, 2021
SELL
$225.08 - $271.69 $4.59 Million - $5.54 Million
-20,398 Reduced 16.67%
101,981 $27.4 Million
Q1 2021

Apr 06, 2021
SELL
$212.38 - $245.9 $607,406 - $703,274
-2,860 Reduced 2.28%
122,379 $27.7 Million
Q4 2020

Jan 11, 2021
SELL
$212.5 - $245.46 $1.25 Million - $1.44 Million
-5,885 Reduced 4.49%
125,239 $27.8 Million
Q3 2020

Oct 08, 2020
SELL
$177.16 - $215.33 $807,849 - $981,904
-4,560 Reduced 3.36%
131,124 $28.2 Million
Q2 2020

Jul 08, 2020
SELL
$128.7 - $176.83 $1.89 Million - $2.6 Million
-14,718 Reduced 9.79%
135,684 $24 Million
Q1 2020

Apr 15, 2020
SELL
$121.39 - $169.05 $764,271 - $1.06 Million
-6,296 Reduced 4.02%
150,402 $20.8 Million
Q4 2019

Jan 10, 2020
SELL
$133.47 - $153.48 $5,872 - $6,753
-44 Reduced 0.03%
156,698 $24.1 Million
Q3 2019

Oct 07, 2019
SELL
$135.4 - $146.47 $21,664 - $23,435
-160 Reduced 0.1%
156,742 $22.6 Million
Q2 2019

Jul 10, 2019
SELL
$124.88 - $143.73 $453,439 - $521,883
-3,631 Reduced 2.26%
156,902 $22.4 Million
Q1 2019

Apr 05, 2019
SELL
$97.62 - $132.29 $119,291 - $161,658
-1,222 Reduced 0.76%
160,533 $21.2 Million
Q4 2018

Jan 07, 2019
SELL
$94.85 - $109.54 $50,270 - $58,056
-530 Reduced 0.33%
161,755 $16.7 Million
Q3 2018

Oct 12, 2018
BUY
$98.13 - $108.9 $99,111 - $109,989
1,010 Added 0.63%
162,285 $17.6 Million
Q2 2018

Jul 12, 2018
SELL
$96.1 - $103.24 $6,534 - $7,020
-68 Reduced 0.04%
161,275 $15.9 Million
Q1 2018

Apr 11, 2018
SELL
$92.16 - $103.8 $9,861 - $11,106
-107 Reduced 0.07%
161,343 $15.8 Million
Q4 2017

Jan 10, 2018
BUY
$85.26 - $94.62 $44,249 - $49,107
519 Added 0.32%
161,450 $15 Million
Q3 2017

Oct 13, 2017
BUY
$79.29 - $88.45 $12.8 Million - $14.2 Million
160,931
160,931 $13.8 Million

Others Institutions Holding DHR

# of Institutions
2,389
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.1M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $201B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email